Finance

Lists
Why is 8N10 up 2,50%?
Dive Deeper
8N10:FRA
Biosergen AB
€0,041
+2,50%
(+0,0010) 1D
13 ຕ.ລ., 22 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8N10...
Open
€0,04
High
€0,04
Low
€0,04
Mkt. cap
41,02 ລ້ານ
Volume
0,00
52-wk high
€4,34
52-wk low
€0,04
No. of employees
1
Open
€0,04
High
€0,04
Low
€0,04
Mkt. cap
41,02 ລ້ານ
Volume
0,00
52-wk high
€4,34
52-wk low
€0,04
No. of employees
1
News stories
From web sources and news partners
Seeking Alpha
Seeking Alpha
·
1 ຊົ່ວໂມງກ່ອນ
Three things to look out for on Wednesday
About Biosergen AB
CEOTine Kold Olesen
Employees1
Founded2004
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
131,00 ພັນ
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,73 ລ້ານ
5,88 ລ້ານ
5,33 ລ້ານ
5,33 ລ້ານ
Operating expense
12,19 ລ້ານ
9,67 ລ້ານ
5,24 ລ້ານ
5,24 ລ້ານ
Total operating expenses
12,19 ລ້ານ
9,67 ລ້ານ
5,24 ລ້ານ
5,24 ລ້ານ
Operating income
-12,19 ລ້ານ
-9,67 ລ້ານ
-5,24 ລ້ານ
-5,24 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-12,17 ລ້ານ
-9,66 ລ້ານ
-5,24 ລ້ານ
-5,24 ລ້ານ
EBT excluding unusual items
-12,17 ລ້ານ
-9,66 ລ້ານ
-5,24 ລ້ານ
-5,24 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-537,00 ພັນ
3,79 ລ້ານ
-95,50 ພັນ
-95,50 ພັນ
Net income
-12,17 ລ້ານ
-9,66 ລ້ານ
-5,24 ລ້ານ
-5,24 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-5,00
-
-
-
Interest and investment income
22,00 ພັນ
18,00 ພັນ
-
-
Interest expense
-
-4,00 ພັນ
-7,50 ພັນ
-7,50 ພັນ
Net interest expenses
22,00 ພັນ
14,00 ພັນ
-7,50 ພັນ
-7,50 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google